CCMU
KITE

Cheyne Capital Management (UK)’s Kite Pharma, Inc. KITE Stock Holding History

Cheyne Capital Management (UK)’s Portfolio KITE Stock Details KITE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q4 		– Sell
-92,785
Closed -$16.7M – 43
2017
Q3 		$16.7M Buy
+92,785
New +$12.9M 6.02% 9

Cheyne Capital Management (UK)'s KITE Position: Q4 2017 in Review

Cheyne Capital Management (UK) sold out of Kite Pharma, Inc. (KITE) in Q4 2017, closing a stake of 92,785 shares — an estimated $16.7M sold.

Cheyne Capital Management (UK) first reported a position in KITE in Q3 2017 and held it in 1 quarter. The position peaked at $16.7M in Q3 2017. 0 funds tracked by Wall St. Rank hold KITE as of Q4 2017.

  • Cheyne Capital Management (UK) reported no remaining Kite Pharma, Inc. position as of Q4 2017 after selling out during the quarter.
  • Cheyne Capital Management (UK) sold 92,785 Kite Pharma, Inc. shares in Q4 2017, an estimated $16.7M.
  • Cheyne Capital Management (UK) first reported a position in Kite Pharma, Inc. in Q3 2017 and held it in 1 quarter.
  • Cheyne Capital Management (UK)'s Kite Pharma, Inc. position peaked at $16.7M in Q3 2017.
  • 0 funds tracked by Wall St. Rank held Kite Pharma, Inc. as of Q4 2017.

Based on Cheyne Capital Management (UK)'s 13F filing for Q4 2017, filed 8 Feb 2018.